Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03909828
What this trial is testing

Precision Medical Diagnosis for Parkinson's Disease - The Quantitative Analysis System for PET/MRI Images in Patients

Who this might be right for
Parkinson DiseasePETMRI
Taipei Veterans General Hospital, Taiwan 100
Testing effectiveness (Phase 2)Study completedNCT01759888
What this trial is testing

Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism

Who this might be right for
Parkinson's Disease
Chang Gung Memorial Hospital 49
Early research (Phase 1)Looking for participantsNCT07422675
What this trial is testing

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

Who this might be right for
PARKINSON DISEASE (Disorder)Advanced Parkinson's Disease
Serina Therapeutics 40
Not applicableUnknownNCT04706065
What this trial is testing

SHMT1 Polymorphism in Parkinson's Disease,

Who this might be right for
Study the Role of SHMT1 Polymorphism in Parkinson Disease
Assiut University 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07471230
What this trial is testing

Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism

Who this might be right for
Parkinsonism or Parkinson's Disease NosParkinsonism in Diseases Classified Elsewhere
Biocells Medical 120
Post-approval studies (Phase 4)Looking for participantsNCT06765668
What this trial is testing

CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Who this might be right for
Parkinson Disease
Impax Laboratories, LLC 220
Not applicableActive Not RecruitingNCT05963425
What this trial is testing

The Effects on Physical Activity on Mitochondrial Function in Skin Fibroblasts in Patients with Parkinson's Disease.

Who this might be right for
Parkinson's Disease
University Ramon Llull 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04127578
What this trial is testing

Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)

Who this might be right for
Parkinson Disease
Prevail Therapeutics 32
Not applicableStudy completedNCT01592552
What this trial is testing

A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery

Who this might be right for
Alzheimer's DiseaseMultiple SclerosisParkinson's Disease+2 more
Sanguine Biosciences 20
Post-approval studies (Phase 4)UnknownNCT00354133
What this trial is testing

Controlled Trial With Deep Brain Stimulation in Patients With Early Parkinson's Disease

Who this might be right for
Parkinson Disease
German Parkinson Study Group (GPS) 251
Not applicableLooking for participantsNCT07449117
What this trial is testing

Effect of Striatal Temporal Interference Stimulation on Language Processing in Neurodegenerative Diseases

Who this might be right for
Mild Cognitive Impairment (MCI) AmnesticLewy Body Disease With Mild Cognitive ImpairmentParkinson's Disease With Mild Cognitive Impairment
Masaryk University 70
Testing effectiveness (Phase 2)Ended earlyNCT01955616
What this trial is testing

Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation

Who this might be right for
Parkinson's Disease
Motus Therapeutics, Inc. 18
Not applicableEnded earlyNCT05349019
What this trial is testing

A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease

Who this might be right for
Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene
Escape Bio, Inc. 22
Not applicableLooking for participantsNCT07175922
What this trial is testing

Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease

Who this might be right for
Parkinsons Disease (PD)
Vertero Therapeutics 200
Large-scale testing (Phase 3)Study completedNCT01628965
What this trial is testing

A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 143
Not applicableLooking for participantsNCT07662837
What this trial is testing

Effects of Tai Chi Therapy Versus Qi-Gong in Stage-I Parkinson's Patients.

Who this might be right for
PARKINSON DISEASE (Disorder)
Lahore University of Biological and Applied Sciences 50
Not applicableUnknownNCT02365012
What this trial is testing

Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using Midodrine

Who this might be right for
Orthostatic IntoleranceParkinson's Disease
Corporal Michael J. Crescenz VA Medical Center 50
Not applicableLooking for participantsNCT04848077
What this trial is testing

STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's Disease

Who this might be right for
Movement DisordersParkinson Disease
Radboud University Medical Center 452
Not applicableStudy completedNCT03782753
What this trial is testing

Molecular Pathology and Neuronal Networks in LRRK2 Parkinson's Disease

Who this might be right for
Parkinson Disease, PARK8Parkinson DiseaseIdiopathic Parkinson Disease
King's College London 59
Large-scale testing (Phase 3)Ended earlyNCT01927055
What this trial is testing

A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionParkinson's DiseaseMultiple Systems Atrophy+2 more
Chelsea Therapeutics 61
Next Page